Board Meeting11 May 2026, 07:11 pm
Sun Pharma Advanced Research Board Meeting on May 18, 2026
AI Summary
Sun Pharma Advanced Research Company Ltd has scheduled a Board of Directors meeting on May 18, 2026, to consider and approve the audited standalone and consolidated financial results for the quarter and financial year ended March 31, 2026. The trading window for dealing in the company's shares has been closed from April 01, 2026, and will remain closed until 48 hours after the financial results are declared.
Key Highlights
- Board meeting scheduled for May 18, 2026, to approve audited financial results.
- Consideration of standalone and consolidated results for FY26.
- Trading window closed from April 1, 2026, until 48 hours post results declaration.
Price Impact
More from SPARC